SCHEMBL7045839

SCHEMBL7045839

COc1cc(-c2nn(C3CCNCC3)c3ncnc(N)c23)ccc1NC(=O)c1cc2cc([N+](=O)[O-])ccc2o1.COc1cc(-c2nn(C3CCNCC3)c3ncnc(N)c23)ccc1NC(=O)c1oc2ccccc2c1C

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LCK P06239 20/20 0.61
SRC P12931 10/20 0.61
TEK Q02763 8/20 0.61
FYN P06241 3/20 0.48
LIMK1 P53667 2/20 0.47
PLK4 O00444 1/20 0.47
AURKA O14965 1/20 0.47
PAK4 O96013 1/20 0.47
CHEK2 O96017 1/20 0.47
ABL1 P00519 1/20 0.47
EGFR P00533 1/20 0.47
ERBB2 P04626 1/20 0.47
NTRK1 P04629 1/20 0.47
INSR P06213 1/20 0.47
CSF1R P07333 1/20 0.47
LYN P07948 1/20 0.47
HCK P08631 1/20 0.47
FGR P09769 1/20 0.47
FLT1 P17948 1/20 0.47
MAPK1 P28482 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4826428 0.92 LCK (0.65) LCKSRCTEKFYNLIMK1
SCHEMBL4826559 0.90 LCK (0.63) LCKSRCTEKFYNLIMK1
SCHEMBL4821436 0.86 LCK (0.80) LCKSRCTEKFYNLIMK1
SCHEMBL5823953 0.84 LCK (0.69) LCKSRCTEKFYNLIMK1
SCHEMBL6218794 0.83 LCK (0.69) LCKSRCTEKFYNLIMK1
SCHEMBL6278841 0.83 LCK (0.69) LCKSRCTEKFYNLIMK1
Acetic Acid SCHEMBL4828254 0.81 LCK (0.67) LCKSRCTEKFYNLIMK1
SCHEMBL4820493 0.81 LCK (0.68) LCKSRCTEKFYNLIMK1
SCHEMBL7050233 0.81 LCK (0.66) LCKSRCTEKFYNLIMK1
Acetic Acid SCHEMBL6245563 0.80 LCK (0.66) LCKSRCTEKFYNLIMK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004100868-A2 METHOD OF TREATING TRANSPLANT REJECTION ABBOTT LABORATORIES (US) 2004-11-25 WO disclosed